<code id='D2BDC12AFF'></code><style id='D2BDC12AFF'></style>
    • <acronym id='D2BDC12AFF'></acronym>
      <center id='D2BDC12AFF'><center id='D2BDC12AFF'><tfoot id='D2BDC12AFF'></tfoot></center><abbr id='D2BDC12AFF'><dir id='D2BDC12AFF'><tfoot id='D2BDC12AFF'></tfoot><noframes id='D2BDC12AFF'>

    • <optgroup id='D2BDC12AFF'><strike id='D2BDC12AFF'><sup id='D2BDC12AFF'></sup></strike><code id='D2BDC12AFF'></code></optgroup>
        1. <b id='D2BDC12AFF'><label id='D2BDC12AFF'><select id='D2BDC12AFF'><dt id='D2BDC12AFF'><span id='D2BDC12AFF'></span></dt></select></label></b><u id='D2BDC12AFF'></u>
          <i id='D2BDC12AFF'><strike id='D2BDC12AFF'><tt id='D2BDC12AFF'><pre id='D2BDC12AFF'></pre></tt></strike></i>

          Home / knowledge / explore

          explore


          explore

          author:fashion    Page View:1952
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In